Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p

Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression

(2020) Xianglu Ji et al.   Cell Death & Disease

Molecular Biology of Osteosarcoma

(2020) Anna M. Czarnecka et al.   Cancers

Osteosarcoma: A comprehensive review of management and treatment strategies

(2020) Farzaneh Jafari et al.   Annals of Diagnostic Pathology

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance

(2020) Theresa Klümper et al.   Experimental Hematology & Oncology

Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR‐1227/ IRF2 axis

(2020) Xin Jiang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Circular RNA Circ-03955 Promotes Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating miR-3662/Metadherin Pathway

(2020) Zhengguang Wang et al.   Frontiers in Oncology

Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer

(2019) Lijian Chen et al.   Molecular Cancer

Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance

(2019) Kun-Peng Zhu et al.   MOLECULAR THERAPY

miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes

(2019) Xiaodi Li et al.   BIOCHEMICAL PHARMACOLOGY

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

(2019) Yuting Sang et al.   MOLECULAR THERAPY

Past, present, and future of circ RNA s

(2019) Ines Lucia Patop et al.   EMBO JOURNAL

Circular RNAs in Cancer

(2019) Duc-Hiep Bach et al.   Molecular Therapy-Nucleic Acids

The biogenesis, biology and characterization of circular RNAs

(2019) Lasse S. Kristensen et al.   NATURE REVIEWS GENETICS

The circular RNA circ-ITCH acts as a tumour suppressor in osteosarcoma via regulating miR-22

(2019) Chongmin Ren et al.   Artificial Cells Nanomedicine and Biotechnology

CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling

(2019) Junxin Chen et al.   Molecular Cancer

Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1

(2018) Zhu Kun-Peng et al.   International Journal of Biological Sciences

Hsa_circRNA_103809 regulated the cell proliferation and migration in colorectal cancer via miR-532–3p / FOXO4 axis

(2018) Longjun Bian et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma

(2018) Zhu Kun-Peng et al.   International Journal of Biological Sciences

The Biogenesis, Functions, and Challenges of Circular RNAs

(2018) Xiang Li et al.   MOLECULAR CELL

Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing

(2018) Zhu Kun-Peng et al.   Epigenomics

NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142–5p

(2018) Jiancheng Su et al.   PHARMACOGENOMICS

Circular RNAs: Identification, biogenesis and function

(2016) Karoline K. Ebbesen et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

An update on chemotherapy for osteosarcoma

(2015) Stefano Ferrari et al.   EXPERT OPINION ON PHARMACOTHERAPY

Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?

(2013) Norio Yamamoto et al.   EXPERT OPINION ON PHARMACOTHERAPY

miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma

(2012) K. B. Jones et al.   CANCER RESEARCH